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† Conclusion
background: The prevalence of congenital uterine anomalies in high-risk women is unclear, as several different diagnostic approaches
have been applied to different groups of patients. This review aims to evaluate the prevalence of such anomalies in unselected populations
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Advanced Access publication on June 24, 2011 doi:10.1093/humupd/dmr028and in women with infertility, including those undergoing IVF treatment, women with a history of miscarriage, women with infertility and
recurrent miscarriage combined, and women with a history of preterm delivery.
methods: Searches of MEDLINE, EMBASE, Web of Science and the Cochrane register were performed. Study selection and data extrac-
tion were conducted independently by two reviewers. Studies were grouped into those that used ‘optimal’ and ‘suboptimal’ tests for uterine
anomalies. Meta-analyses were performed to establish the prevalence of uterine anomalies and their subtypes within the various populations.
results: We identiﬁed 94 observational studies comprising 89 861 women. The prevalence of uterine anomalies diagnosed by optimal
tests was 5.5% [95% conﬁdence interval (CI), 3.5–8.5] in the unselected population, 8.0% (95% CI, 5.3–12) in infertile women, 13.3% (95%
CI, 8.9–20.0) in those with a history of miscarriage and 24.5% (95% CI, 18.3–32.8) in those with miscarriage and infertility. Arcuate uterus is
most common in the unselected population (3.9%; 95% CI, 2.1–7.1), and its prevalence is not increased in high-risk groups. In contrast,
septate uterus is the most common anomaly in high-risk populations.
conclusions: Women with a history of miscarriage or miscarriage and infertility have higher prevalence of congenital uterine
anomalies compared with the unselected population.
Key words: congenital uterine anomalies / prevalence / miscarriage / preterm / uterus
Introduction
Congenital uterine anomalies result from abnormal formation,
fusion or resorption of the Mu ¨llerian ducts during fetal life
(Moore et al., 2008). These anomalies have been associated with
an increased rate of miscarriage, preterm delivery and other
adverse fetal outcomes (Green and Harris, 1976; Rock and
Schlaff, 1985; Acien, 1993; Raga et al., 1997; Grimbizis et al.,
2001; Tomazevic et al., 2007).
However, such associations might be artefactual. The true popu-
lation prevalence of congenital uterine anomalies is difﬁcult to assess
partly because there are no universally agreed standardized classiﬁ-
cation systems and partly because the best diagnostic techniques are
invasive and, therefore, rarely applied to low-risk study populations.
As a result, reported population prevalence rates have varied
between 0.06% and 38% (Simon et al., 1991; Makino et al., 1992a, b;
Clifford et al., 1994; Acien, 1996; Homer et al., 2000; Guimaraes
Filho et al., 2006a, b). This wide variation is likely to be linked to
the assessment of different patient populations and the use of different
diagnostic techniques with variable, and yet to be determined, test
accuracy as well as reliance on non-standardized classiﬁcation
systems. Previous reviews have not considered these factors when
investigating the prevalence of uterine anomalies (Acien, 1997;
Nahum, 1998; Grimbizis et al., 2001; Troiano and McCarthy, 2004).
Saravelos et al. (2008) carried out a critical review to determine the
prevalence of congenital uterine anomalies. Their review has assessed
the accuracy of different diagnostic procedures, but their search was
limited to MEDLINE database and speciﬁcally limited to recurrent mis-
carriage, infertile and general population groups.
We conducted a systematic review of studies evaluating the
prevalence of congenital uterine anomalies in the unselected popu-
lation and in women with a history of infertility, including those
undergoing IVF treatment, miscarriage, infertility and recurrent
miscarriage combined, and preterm delivery and attempted to
explore the inconsistencies present in the literature. This new
systematic review is not only an update of the work by Saravelos
et al. (2008) but also represents a different approach to the
classiﬁcation of optimal and suboptimal tests.
Methods
Search strategy
Articles were identiﬁed through the following electronic databases:
MEDLINE (1950 to March 2011), EMBASE (1980 to March 2011), Web
of Science (1990 to March 2011) and the Cochrane Central Register of
Controlled Trials (The Cochrane Library until January 2011). A combi-
nation of Medical Subject Headings (MeSH) and text words were used to
generate the list of citations (Table I). In addition, the reference lists of all
relevant primary studies and review articles were manually searched to
identify additional cited articles not captured by the electronic searches.
Authors were contacted for additional details where required. The
searcheswereconductedindependentlybytworeviewers(Y.Y.C.andK.J.).
The search terms in Table I were designed speciﬁcally for MEDLINE.
This search was modiﬁed for EMBASE, Web of Science and the Cochrane
Library.
Selection criteria
Studies were selected if the incidence of any uterine anomaly was
reported. Studies of all types of congenital uterine anomalies were
included but limited to ‘Humans and Female’. Only cohort studies were
included in the review. Studies were excluded when the population exam-
ined or the diagnostic methods used were not accurately deﬁned. Only
publications in English were considered in our selection.
The classiﬁcation system for uterine anomalies was adapted from the
American Fertility Society guidelines (1988). The arcuate uterus is an
anomaly where the uterine fundus displays a mild concave indentation
or contour towards the uterine cavity (The American Fertility Society,
1988; Salim et al., 2003). Many authors consider the arcuate uterus a
normal variant rather than a true anatomical or developmental anomaly
(Heinonen et al., 1982; Buttram et al., 1988), but this can only be properly
evaluated if the true prevalence of the anomaly can be deﬁned and appro-
priate associations with relevant outcome measures assessed. Neither can
be assessed in the absence of an accurate test to identify the anomaly and
differentiate it from more complex uterine anomalies and the normal
uterus. In view of this, studies that failed to identify or record any
arcuate uteri were excluded from the subtype analysis as we were
unable to determine if these studies excluded arcuate uteri or if they
failed to identify them because of the inaccuracy of the diagnostic tests
employed.
762 Chan et al.Study selection
Studies were selected in a two-stage process. First, the titles and abstracts
from the electronic searches were examined independently by two
reviewers (Y.Y.C. and K.J.) and full manuscripts of all citations that met
the predeﬁned selection criteria were then obtained. Secondly, examin-
ations of the full manuscripts were carried out to make ﬁnal inclusion or
exclusion decisions. In cases of duplicates, the most recent or the most
complete publication was used. Any disagreements about inclusion were
resolved by consensus or arbitration by a third reviewer (N.R.-F.).
All selected papers were assessed for the following: study design;
adequate sampling (random or consecutive rather than convenience
sampling); adequate description of population characteristics; complete-
ness of information in the data sets; and use of a validated diagnostic
method.
Data collection and extraction
Data collection and extraction were performed by the two reviewers
(Y.Y.C. and K.J.) independently. Data were extracted on patients’ charac-
teristics, study quality, inclusion and exclusion criteria, diagnostic tools
used and anomaly occurrence rates.
In assessing the prevalence of congenital uterine anomalies, investigators
have used different diagnostic methods, some of which may be more accu-
rate or reliable than others. In view of this, we grouped the studies into
two classes according to the diagnostic accuracy of the methods used
based on evidence from other studies (Scarsbrook and Moore, 2003; Sar-
avelos et al., 2008; Olpin and Heilbrun, 2009). Diagnostic methods that
were accepted as ‘optimal diagnostic tests’ included three-dimensional
transvaginal ultrasound, laparoscopy or laparotomy performed in conjunc-
tion with hysteroscopy or hysterosalpingography (HSG), magnetic reson-
ance imaging (MRI) and saline sonohysterography. Suboptimal tests,
which could identify and differentiate most but not all anomalies, included
two-dimensional transvaginal ultrasound, hysteroscopy performed in iso-
lation, HSG and clinical assessment at the time of Caesarean section.
We devised this classiﬁcation based on the ability of the test to demon-
strate both the external contour of the uterus and the fundal aspect of
the endometrial cavity.
Statistical analysis
Meta-analyses were performed to establish the prevalence of uterine
anomalies, and their subtypes, in each group of women. For
meta-analyses, log rates were pooled, weighting each study by the
inverse of its variance, and the summary estimates were exponentiated.
A random-effects model was used for analysis. Comparisons between
the unselected population and the high-risk populations were carried
out with the aid of meta-regression. Statistical analyses were performed
using Stata 11.0 statistical software (Stata Corp, TX, USA).
Results
All uterine anomalies
The search yielded 6266 citations; of which, 1413 duplicates were
excluded (Fig. 1). Another 4306 were excluded, as it was clear from
the title and abstract that they did not fulﬁl the selection criteria.
Full manuscripts were obtained for the remaining 547 articles from
which, following scrutiny of each article, we identiﬁed 91 potentially
relevant studies. Three additional studies, identiﬁed from manual
searches, were also included resulting in 94 studies comprising
89 861 women (Supplementary data, Table SI).
Studies were grouped according to the characteristics of the
different patient population, namely unselected or general population,
infertility, miscarriage, infertility and recurrent miscarriage combined,
and preterm delivery. However, no appropriate study investigating
the prevalence of uterine anomalies in women with preterm deliveries
was available.
Out of the 94 studies included, 59 were prospective, 26 retrospec-
tive and 9 did not deﬁne this aspect of study design. Seventy-nine
studies had consecutive or random patient recruitment. Forty-one
out of 94 (44%) studies used optimal diagnostic tests. Pooled preva-
lence rates for all uterine anomalies and various subgroups are
shown in Table II.
Figure 1 The study selection process for the systematic review on
the prevalence of uterine anomalies in unselected and high-risk
populations.
........................................................................................
Table I Search terms (Unless otherwise stated, search
terms were free text terms; mp, term appears in title,
original title, abstract, name of substance word,
subject heading word; $, any character).
Search terms Search terms
Uterine anomal$.mp Unicornuate.mp
Uterine abnormalit$.mp Bicornuate.mp
Mu ¨llerian anoaml$.mp Arcuate uter$.mp
Mu ¨llerian abnormalit$.mp Septate$ uter$.mp
Uter$ agenesis.mp Subseptate$ uter$.mp
Uter$ hypoplasia.mp Subseptate$ uter$.mp
Biﬁd uter$.mp T shape$ uter$.mp
Didelphys.mp T-shape$ uter$.mp
Didelphus.mp
The prevalence of congenital uterine anomalies 763Overall, 5.5% [95% conﬁdence interval (CI), 3.5–8.5] of the unse-
lected population were shown to have a uterine anomaly diagnosed by
an optimal test. The prevalence was not increased in women with
infertility (8.0%; 95% CI, 5.3–12.0, P ¼ 0.239) when compared with
the unselected population. Women with a history of miscarriage
(13.3%; 95% CI, 8.9–20; P ¼ 0.011) and miscarriage in association
with infertility (24.5%; 95% CI, 18.3–32.8; P , 0.001) were all
shown to have signiﬁcantly higher rates of uterine anomalies than
the unselected population. The prevalence of congenital uterine
anomalies diagnosed by optimal tests in women with two or more
miscarriages (10.9%; 95% CI, 3.6–33.3) was not signiﬁcantly different
(P ¼ 0.572) from those with three or more miscarriages (15.4%; 95%
CI, 10.3–23). The prevalence of all uterine anomalies in various
populations diagnosed by suboptimal tests was found to be consistent
with those diagnosed by optimal tests.
Arcuate uteri
Arcuate uteri are common in the unselected population affecting 3.9%
(95% CI, 2.1–7.1) of all women. Their prevalence, as diagnosed by
an optimal test, is not increased in infertile women (1.8%; 95% CI,
0.8–4.1) or in women with a history of miscarriage (2.9%; 95% CI,
0.9–9.6) when compared with the unselected population.
Suboptimal tests gave a prevalence for arcuate uteri of 2.2% (95%
CI, 0.9–5.2) in the unselected population. The prevalence rates for
anomalies diagnosed by suboptimal tests were inconsistent with the
ﬁndings of the optimal tests, with a higher prevalence of arcuate
uteri in women with miscarriage (8.9%; 95% CI, 6.4–12.4,
P ¼ 0.019) when the former were used.
Canalization defects
Canalization defects, namely subseptate or septate uteri, have a preva-
lence of 2.3% (95% CI, 1.8–2.9) in the unselected population when
optimal tests are used to deﬁne their presence. They are no more
prevalent in women with infertility in general (3.0%; 95% CI, 1.3–
6.7, P ¼ 0.422) compared with the unselected population. Canaliza-
tion defects are, however, signiﬁcantly more common in women
with miscarriage (5.3%; 95% CI, 1.7–16.8, P ¼ 0.021), especially if
this is combined with a history of infertility (15.4%; 95% CI, 12.5–
19, P , 0.001).
Suboptimal tests gave a prevalence for canalization defects of 0.2%
(95% CI, 0–0.9) of women in the unselected population; a 10-fold
reduction in prevalence compared with the rates with optimal tests
(P ¼ 0.001). The prevalence of canalization defects in various high-risk
populations diagnosed by suboptimal tests was consistent with those
diagnosed by optimal tests.
Uniﬁcation defects
Uniﬁcation defects include bicornuate, unicornuate and didelphic uteri.
Bicornuate uteri, which are uncommon in the unselected population
(0.4%; 95% CI, 0.2–0.6), are signiﬁcantly more prevalent in women
with infertility (1.1%; 95% CI, 0.6–2.0, P ¼ 0.032) and those with mis-
carriage (2.1%; 95% CI, 1.4–3, P , 0.001), particularly if these coexist
(4.7%; 95% CI, 2.9–7.6, P , 0.001).
Overall, 0.1% (95% CI, 0.1–0.3) of the unselected population had a
unicornuate uterus diagnosed by an optimal test. However, unicornu-
ate uterus is signiﬁcantly more common in women with a history of
.
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764 Chan et al.miscarriage (0.5%; 95% CI, 0.3–1.1; P ¼ 0.025), miscarriage in associ-
ation with infertility (3.1%; 95% CI, 2–4.7; P , 0.001) and infertility
(0.5%; 95% CI, 0.3–0.8, P ¼ 0.01) when compared with the unse-
lected population. The prevalence of uterus didelphys was 0.3%
(95% CI, 0.1–0.6) in the unselected population. This anomaly is no
more prevalent in women with infertility (0.3%; 95% CI, 0.2–0.5),
or in women with a history of miscarriage (0.6%; 95% CI, 0.3–1.4),
but is signiﬁcantly more common in infertile women with miscarriage
(2.1%; 95% CI, 1.4–3.2, P , 0.001).
Overall, the prevalence of uniﬁcation defects in various populations
diagnosed by suboptimal tests is consistent with those diagnosed by
optimal tests.
Discussion
Our systematic review evaluated the prevalence of uterine abnormal-
ities in the general ‘unselected’ population and in various high-risk
groups stratiﬁed according to the diagnostic accuracy of the tests
used to identify and deﬁne the anomaly. The review is not only an
update of the work by Saravelos et al. (2008) but also represents a
different perspective on the classiﬁcation of optimal and suboptimal
tests. In our review, optimal tests are investigations that are capable
of accurately identifying and classifying congenital uterine anomalies
accurately while suboptimal tests can identify and differentiate most
but not all anomalies. In addition, the review by Saravelos et al.
(2008) has not described the literature search and the study selection
in detail. They have also limited their search to mainly MEDLINE data-
base and some relevant articles are likely to be missed. Our compre-
hensive search and study selection using multiple databases have
captured most, if not all relevant articles. Therefore, more papers
were found for this review compared with Saravelos et al. (2008).
We have also prospectively subclassiﬁed infertility by separating
women who have infertility only and those who have combined infer-
tility and miscarriage. It is important to subclassify infertility into these
groups as they are likely to have clinically distinct problems, as
described below.
Principal ﬁndings
In our review, we found that the prevalence of all congenital uterine
anomalies diagnosed by optimal tests in the unselected population
was 5.5%. This appears to be increased in women with a history of
miscarriage and those who have combined infertility and miscarriage.
Subgroup analyses showed that the speciﬁc anomalies, which are
increased in these high-risk populations, are mainly canalization
defects, namely subseptate or septate uteri, and uniﬁcation defects.
Weaknesses of our review
Our review is limited by the retrospective nature of the analysis and
heterogeneity of the patient population and diagnostic tests applied.
We were unable to obtain all relevant clinical information for all of
the women studied. We included all studies that met the selection cri-
teria but did not exclude studies because of inadequate quality. We
have found that several analyses showed statistically signiﬁcant hetero-
geneity, which is most likely due to different patient populations,
varied diagnostic tests and classiﬁcation systems used.
There was clearly a lack of uniformity with the classiﬁcation of
uterine anomalies in the studies included. The most commonly used
classiﬁcation system is the one devised by the American Fertility
Society in 1988, but this does not specify the diagnostic methods
that should be used and the ﬁnal diagnosis is based on the subjective
impression of the clinician performing the test (Woelfer et al., 2001).
Strengths of our review
The strengths of our systematic review include its extensive electronic
search using multiple databases and manual search approach. We
attempted to address the problem of clinical heterogeneity by analys-
ing different patient populations separately and by analysing the two
groups of diagnostic tests used as suboptimal or optimal. We also con-
sider our classiﬁcation of which tests offer an optimal diagnosis and
differentiation of uterine anomalies is more robust and relevant than
the one used by Saravelos et al. (2008).
Diagnostic tests
Ingeneral,ourreviewisinagreementwiththeﬁndingsbySaravelosetal.
(2008). An important difference is, however, an overall lower preva-
lence of all anomalies in our review. This may reﬂect our different view-
points on what constitutes an optimal diagnostic test for the
identiﬁcation and differentiation of uterine anomalies. We believe that
two-dimensional transvaginal ultrasound, hysteroscopy and HSG are
suboptimal in this respect, as they all have a tendency to misclassify
uterineabnormalitiesowingtotheirpooreraccuracywhenusedasdiag-
nostictestsinisolation(Jurkovicetal.,1995;Wuetal.,1997;Braunetal.,
2005; Andreotti et al., 2006; Guimaraes Filho et al., 2006a, b; Momtaz
et al., 2007). This is particularly true of the more minor abnormalities,
suchasthearcuateandsubseptateuteri,whichmaybemissedorincor-
rectlyclassiﬁed.Mostofthesetestsdonotallowevaluationoftheexter-
nal contour of the uterus and are, therefore, unable to reliably
differentiatea septate uterus from one thatis subseptate or bicornuate.
These suboptimal tests, however, are likely to perform better when
major uterine anomalies are considered as these are more readily
evident and theoretically, at least, easier to differentiate from one
another with the exception of the more complex anomalies that
involve the cervix and non-communicating corpora.
It is surprising, therefore, that our systematic review showed that
prevalence of uterine anomalies in various populations is similar
regardless of whether an optimal or suboptimal test was used. In con-
trast, Saravelos et al. (2008) reported signiﬁcant differences in the
prevalence of all uterine anomalies according to the purported accu-
racy of the diagnostic test. Their systematic review and meta-analysis
considered hysteroscopy alone as an accurate test while MRI has
unclear diagnostic accuracy. Hysteroscopy does not allow evaluation
of the external contour of the uterus and, therefore, we considered
hysteroscopy as a suboptimal test. In our opinion, MRI is an optimal
test that allows a simultaneous assessment of the cavity and fundus
of the uterus. MRI has been reported to have a high accuracy rate
in diagnosing congenital uterine anomalies (Pellerito et al., 1992;
Fischetti et al., 1995; Olpin and Heilbrun, 2009; Bermejo et al.,
2010). MRI can also be used to extend the examination to the
abdomen, which is potentially important because of the increased fre-
quency of renal anomalies in patients with uterine anomalies
(Gell et al., 1998; Li et al., 2000; Arnold et al., 2001).
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Preterm labour has many aetiologies, but congenital anomalies have
been suggested as one potential cause. Putative mechanisms include
cervical incompetence (Airoldi et al., 2005), abnormal uterine contrac-
tions (Dabirashraﬁ et al., 1995) and reduced uterine volume (Reuter
et al., 1989; Pellerito et al., 1992; Braun et al., 2005; Puscheck and
Cohen, 2008). Unfortunately, despite these links, no appropriate
studies investigating the prevalence of uterine anomalies in women
with preterm delivery were identiﬁed in the search.
The unselected or general population
In our review, the prevalence of all congenital uterine anomalies diag-
nosed by optimal tests in the unselected population was 5.5%. This is
higher than reported in many reviews, which suggested a rate of 0.17–
4.3% (Simon et al., 1991; Raga et al., 1997; Nahum, 1998; Homer
et al., 2000; Grimbizis et al., 2001) but lower than the recent systema-
tic review by Saravelos et al. (2008), which suggested that 6.7% of all
women have a uterine anomaly (Saravelos et al., 2008). These differ-
ences, as discussed above, are likely to reﬂect the different diagnostic
tests used and varied clinical backgrounds in the different study
populations.
The most common uterine anomaly diagnosed in the unselected
population is the arcuate uterus (3.9%), followed by the canalization
defects (2.3%) and then the bicornuate uterus (0.4%). This is not con-
sistent with the ﬁndings from other studies or reviews, which have
generally found canalization defects to be the most common (Nasri
et al., 1990; Simon et al., 1991; Acien, 1997; Raga et al., 1997;
Homer et al., 2000; Grimbizis et al., 2001). This discrepancy is again
likely to reﬂect the lack of a uniform system for classiﬁcation and poss-
ibly the misclassiﬁcation of some arcuate uteri as normal or small sub-
septate uteri.
Assessing the prevalence of congenital uterine anomalies in the
unselected population is difﬁcult. Many anomalies remain asympto-
matic and investigations are not warranted without speciﬁc indication.
In our review, we have included patients undergoing sterilization
(laparoscopically or hysteroscopically) and those being investigated
for non-obstetric or fertility problems, such as pelvic pain, abnormal
bleeding, ovarian cancer screening and suspected pelvic pathology.
Our results should, therefore, reﬂect the prevalence of uterine
anomalies in the fertile and general population combined, but the
background and various presentations may affect the results. To the
best of our knowledge, no studies have assessed a truly unselected
population where subjects are recruited randomly from the general
public as opposed to those undergoing medical assessment.
The infertile population
The effect of uterine anomalies on fertility is unclear, as are the patho-
physiological processes underlying any potential detrimental effect. In
our systematic review, the infertile population included women with
both primary and secondary infertility. We found that women with
infertility had a similar rate of uterine anomalies (8.0%), when com-
pared with the unselected population, regardless of whether the diag-
nosis was made using optimal or suboptimal tests. This is in agreement
with several other studies that have not shown an increased frequency
of uterine anomalies in women known to have infertility (Acien, 1997;
Grimbizis et al., 2001; Saravelos et al., 2008). In contrast, Taylor and
Gomel (2008) suggested that congenital anomalies might negatively
inﬂuence the complex processes of embryo implantation. Nahum
(1998) reported a prevalence of 3.5% in women with infertility,
which was 21 times more than the incidence of uterine anomalies in
women with normal fertility but did not consider the reliability of
the diagnostic tests used.
Canalization defect is the most common uterine anomaly in optimal
tests in women with infertility (3.0%). This prevalence is comparable
to the unselected population and in accordance with the ﬁndings of
Homer et al. (2000) but lower than that suggested by Saravelos
et al. (2008). Saravelos et al. (2008), as previously discussed, con-
sidered hysteroscopy as a reliable and accurate test to identify canali-
zation defects. They have also included women with miscarriage as
part of their infertile population whom we have considered as separ-
ate subgroup(s). Our review shows that bicornuate uteri are more
prevalent, and certainly not uncommon, in women with infertility
(1.1%) compared with the unselected population (0.4%). This
ﬁnding is in agreement with Saravelos et al. (2008) and Raga et al.
(1997) and suggests a possible association between the bicornuate
uterus and implantation.
Women with miscarriage
The estimated prevalence of uterine anomalies diagnosed by optimal
tests in the population of women with miscarriage is 13.3%, which
is consistent with the literature (Raga et al., 1997; Grimbizis et al.,
2001; Saravelos et al., 2008).
We appreciate that the different studies included used different
inclusion criteria. We have included all studies that investigated
women with miscarriage regardless of the pattern or number of mis-
carriages. However, most studies did not provide clear data as to
whether miscarriage occurred during the ﬁrst or second trimester,
and the studies differ in the pattern of miscarriage, including consecu-
tive and non-consecutive miscarriage, and in the number of previous
miscarriages. It is important to note that most of the studies included
in this current review investigated women with two or more miscar-
riages (Raga et al., 1997; Weiss et al., 2005; Guimaraes Filho et al.,
2006a, b; Dendrinos et al., 2008; Ghi et al., 2009; Bohlmann et al.,
2010; Saravelos et al., 2010) and the results are not, therefore, necess-
arily directly applicable to women with a single previous miscarriage or
those with a previous live birth (a factor that could not be assessed as
it was not reported as a separate group by any author). The preva-
lence of congenital uterine anomalies in women with two or more
miscarriages appears to be similar to those with three or more miscar-
riages, regardless of the diagnostic test used. This is supported by
Weiss et al. (2005) and Saravelos et al. (2008) and suggests that
women with a history of two miscarriages may warrant an investi-
gation to exclude a congenital uterine anomaly.
The observed prevalence of arcuate uteri in the miscarriage popu-
lation is similar to ﬁndings for the unselected population. The preva-
lence of canalization defects in this population is signiﬁcantly higher
than in the unselected population, which supports a contributory
relationship between canalization anomalies and miscarriage. This
ﬁnding is supported by previous studies (Acien, 1993; Woelfer
et al., 2001; Shuiqing et al., 2002).
The exact aetiology and pathophysiological processes of how cana-
lization defects may lead to miscarriage remain uncertain. It has been
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at least suboptimal and this makes it a poor site for implantation
(Candiani et al., 1983; Dabirashraﬁ et al., 1995; Fedele et al., 1996).
Therefore, embryos that do implant on the septum are more likely
to miscarry as a result of this, possibly because the septum has a dis-
orderly and decreased blood supply, which is insufﬁcient to support
subsequent placentation and embryo growth (Candiani et al., 1983;
Raga et al., 1997; Leible et al., 1998; Homer et al., 2000; Kupesic,
2001; Lin, 2004; Rackow and Arici, 2007). These hypotheses remain
to be proven and there is evidence to contradict these theories
(Pellerito et al., 1992; Dabirashraﬁ et al., 1995; Kupesic, 2001). Dabir-
ashraﬁ et al. (1995) have found signiﬁcantly more blood vessles in
biopsy samples of the uterine septum, and Kupesic (2001) found
that patients with vascularized septum had signiﬁcantly higher preva-
lence of early pregnancy failure and late pregnancy complications
than those with avascularized septa (Dabirashraﬁ et al., 1995;
Kupesic, 2001). Other authors have suggested that miscarriage may
result from higher or uncoordinated uterine contractions (Rock and
Murphy, 1986; Pellerito et al., 1992; Dabirashraﬁ et al., 1995;
Kupesic, 2001; Sparac et al., 2001) or a reduced uterine capacity
(Fedele and Bianchi, 1995; Propst and Hill, 2000).
Women with infertility and/or miscarriage
This population of women was found to have signiﬁcantly higher
(24.5%) prevalence of uterine anomalies overall compared with the
unselected population. In keeping with the other high-risk groups,
the most commonly seen anomaly is the canalization defect, which
is signiﬁcantly more prevalent (15.4%) in this population than in the
unselected population (2.3%). It is difﬁcult to know if the higher preva-
lence is related to the presence of women with pure recurrent miscar-
riage or as a result of the inclusion of women who suffered from both
infertility and recurrent miscarriage: it was not possible to separate
these two populations to obtain prevalence information as these
studies did not provide such individual data. Previous reviews have
included these studies in their infertile or recurrent miscarriage popu-
lations (Nahum, 1998; Grimbizis et al., 2001; Saravelos et al., 2010)
but, in our opinion, these women have two potentially clinically
distinct problems and should not be included in these groups.
Distribution of congenital uterine anomalies
Based only on studies employing optimal tests, the most commonly
diagnosed uterine anomaly in the unselected or general population
is the arcuate uterus. The arcuate uterus is, however, no more preva-
lent in any of the high-risk groups studied than in the unselected popu-
lation. Uniﬁcation defects (bicornuate and unicornuate uteri and
uterus didelphys) are generally more prevalent in all of the high-risk
groups as are defects of canalization (septate or subseptate). It is
important to note, however, that some canalization defects may
have been diagnosed as arcuate uteri and vice versa, and equally
some septate uteri, particularly those with a large septum extending
to the cervix, may have been misdiagnosed as bicornuate uteri even
with the use of optimal tests.
Implications for future research
Historically,andstilltoday,manyauthorsconsideredthecombinationof
laparoscopy or laparotomy with hysteroscopy or HSG to be the gold
standard for the diagnosis and differentiation of congenital uterine
anomalies (Acien, 1997; Hamilton et al., 1998; Homer et al., 2000).
The ﬁnal diagnosis is, however, based on the subjective impression of
the clinician performing the test, and in many cases, simultaneous
views of the external contour of the uterus and upper cavity are not
achieved. Because of these limitations and because the combined
approach is also invasive and usually requires general anaesthesia, we
feelthatthree-dimensionalultrasound,ahighlyaccurateyetnon-invasive
test,hasthepotentialtoemergeasthereferencestandardfortheidenti-
ﬁcationanddifferentiationofcongenitaluterineanomalies.Reportshave
shown that three-dimensional ultrasound scan has high sensitivity and
speciﬁcity, as high as 100% in diagnosing uterine anomalies (Carrington
et al., 1990; Pellerito et al., 1992; Deutch and Abuhamad, 2008; Sarave-
los et al., 2008). In addition, theyoffer the ability to assessthe abdomen
simultaneously, which is potentially important owing to increased fre-
quency of renal anomalies in patients with uterine anomalies (Gell
etal.,1998;Lietal.,2000;Arnoldetal.,2001).Three-dimensionalultra-
sound is preferred by some clinicians who use it as a standard to diag-
nose congenital uterine anomalies over MRI (Kupesic, 2005; Deutch
and Abuhamad, 2008) as MRI is more time-consuming and expensive
than ultrasound scanning. Salim et al. (2003) have proposed a modiﬁed
classiﬁcation for three-dimensional ultrasound, in which the diagnostic
criteria used were more detailed than previously described and they
included cut-offs levels for the fundal shape and distortion (Salim et al.,
2003). These cut-offs were necessary to differentiate uterine anomalies
with similar morphological features, such as subseptate and arcuate
uteri. In the future, the Salim et al. (2003) classiﬁcation should be used
as a standard to describe uterine anomalies.
Besides that, there are many different tests available for the diagno-
sis and differentiation of uterine anomalies. A well-designed study of
test accuracy is required to determine the best investigation for diag-
nosis of uterine anomaly.
The results and analyses of our review were hindered by the retro-
spective reporting, and heterogeneity of the patient population, diag-
nostic tests, and classiﬁcation systems applied. In view of this, future
studies should be performed prospectively. Studies should also criti-
cally consider the population being studied and diagnostic test used.
Some studies have reported associations between congenital uterine
anomalies and poor reproductive outcomes (Acien, 1993; Zupi et al.,
1996; Zlopasa et al., 2007). However, further large observational and
prospective studies are essential to investigate the reproductive
impact of different subtypes of congenital uterine anomalies. Studies
are required to assess the management of women with uterine
anomalies as treatments, such as hysteroscopic resection of the
uterineseptum,whichhavebeensuggestedtoimprovethereproductive
outcomesinthesepatients(Maneschietal.,1993;Heinonen,1997;Valli
et al., 2004), arenot without risk and involve irreversible damage to the
endometrium which must be transected to access the myometrium.
While some observational studies have reported an improved
outcome following surgical intervention (Homer et al., 2000; Taylor
and Gomel, 2008), there is a need to conduct randomized controlled
trials to address the effectiveness and safety of such treatment.
Conclusion
In this review, we found that the prevalence of uterine anomalies diag-
nosed by optimal tests was 5.5% in an unselected population, 8% in
The prevalence of congenital uterine anomalies 767infertile women, 13.3% in those with miscarriage and highest at 24.5%
in infertile women who also had a history of miscarriage. The higher
rate of major congenital uterine anomalies in these high-risk groups,
with the exception of isolated subfertility, suggests a causal role in
poor reproductive outcome. The most commonly encountered
anomaly varies according to the population studied with the arcuate
uterus being more prevalent in an unselected group of women and
the canalization defect being the most common anomaly in all of
the high-risk groups. The high prevalence of canalization defects in
high-risk populations should not be underestimated. The role of
septal resection in these women deserves further investigation.
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